Progesterone receptor by immunohistochemistry and clinical outcome in breast cancer: a validation study-Reference-Cited by-同舟云学术

Progesterone receptor by immunohistochemistry and clinical outcome in breast cancer: a validation study

Published:2004-07-23 Issue:12 Volume:17 Page:1545-1554
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Mod Pathol

Author:

Mohsin Syed K,Weiss Heidi,Havighurst Thomas,Clark Gary M,Berardo Melora,Roanh Le D,To Ta V,Zho Qian,Love Richard R,Allred D Craig

Publisher

Springer Science and Business Media LLC

Subject

Pathology and Forensic Medicine

Link

http://www.nature.com/articles/3800229.pdf

Reference46 articles.

1. Early Breast Cancer Trialists' Collaborative Group. Tamoxifen for early breast cancer: an overview of the randomised trials. Lancet 1998;351:1451–1467.

2. Ravdin PM, Green S, Dorr TM, et al. Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group study. J Clin Oncol 1992;10:1284–1291.

3. Fitzgibbons PL, Page DL, Weaver D, et al. Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 2000;124:966–978.

4. American Society of Clinical Oncology. 1997 update of recommendations for the use of tumor markers in breast and colorectal cancer. Adopted on November 7 1997 by the American Society of Clinical Oncology J Clin Oncol 1998;16:793–795.

5. Allred DC . Should immunohistochemical examination replace biochemical hormone receptor assays in breast cancer? Am J Clin Pathol 1993;99:1–3.

Cited by 238 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Simultaneous detection of breast cancer biomarkers circROBO1 and BRCA1 based on a CRISPR-Cas13a/Cas12a system;Biosensors and Bioelectronics;2024-08

2. TRIM47-CDO1 axis dictates hepatocellular carcinoma progression by modulating ferroptotic cell death through the ubiquitin‒proteasome system;Free Radical Biology and Medicine;2024-07

3. Hormone receptor mRNA and protein levels as predictors of premenopausal tamoxifen benefit;ACTA ONCOL;2024

4. Hormone receptor mRNA and protein levels as predictors of premenopausal tamoxifen benefit;Acta Oncologica;2024-04-08

5. Molecular testing in breast cancer;Diagnostic Molecular Pathology;2024